T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum - Contacts and Locations

T4N5 Liposome Lotion Compared With Placebo Lotion for Preventing Actinic Keratoses in Patients With Xeroderma Pigmentosum

This study is ongoing, but not recruiting participants.

Study NCT00002811. Last updated on July 23, 2008. Information provided by National Cancer Institute (NCI)

Please refer to this study by its ClinicalTrials.gov identifier: NCT00002811

Locations


United States, Florida
	Quality Research Group
	Miami Beach, Florida, United States, 33140

United States, Michigan
	University of Michigan Comprehensive Cancer Center
	Ann Arbor, Michigan, United States, 48109-0752

United States, Minnesota
	University of Minnesota Medical School
	Minneapolis, Minnesota, United States, 55455

United States, Missouri
	Washington University School of Medicine
	Saint Louis, Missouri, United States, 63110

United States, New York
	State University of New York Health Sciences Center - Stony Brook
	Stony Brook, New York, United States, 11790-9832

United States, Texas
	University of Texas - MD Anderson Cancer Center
	Houston, Texas, United States, 77030

United States, Washington
	Office of Gerald Bernstein
	Seattle, Washington, United States, 98107

Germany
	Medizinische Klinik
	Munich (Muenchen), Germany, D-80336

United Kingdom, England
	Guy's, King's and St. Thomas' Hospitals Trust
	London, England, United Kingdom, SE1 7EH

Sponsors and Collaborators

Applied Genetics

Investigators


Study Chair:	Daniel B. Yarosh, PhD	Applied Genetics